CD8 + T lymphocytes have been reported to play a major role in the protective immune response against acute infection with Toxoplasma gondii. In order to further assess the role of CD8 + cells in resistance against this protozoan we examined the ability of B2m-deficient mice, which fail to express MHC class I molecules and peripheral CD8 + lymphocytes, to survive tachyzoite challenge following vaccination with an attenuated parasite mutant. Surprisingly, vaccination of B2m-deficient mice induced strong resistance to lethal challenge, with >50% surviving beyond 3 months. Vaccinated ~2m-deficient mice, but not control heterozygotes, showed a five-to sixfold expansion in spleen cell number and "~40% of the splenocytes were found to express the NK markers NKI.1 and asialo GMI. Spleen cells from the vaccinated/~2m-deficient animals failed to kill either infected host cells or the NK target YAC-1. However, high levels of IFN-3~ were secreted when the cells were cultured in vitro with soluble T. gondii lysate, and this response was abolished by NKI.1 § but not CD4 + and CD8 § lymphocyte depletion, implicating the NKI.1 + population as the major source of IFN-% More importantly, vaccine-induced immunity in fl2m-deficient mice was completely abrogated by in vivo administration of antibody to NKI.1, asialo GM1, or IFN-% Together, the data suggest that in class I-deficient mice vaccinated against T. gondii, the absence of CD8 + effector cells is compensated for by the emergence of a population of NKI.1 + and asialo GM1 + cells which lack cytolytic activity, and that the protective action of these cells against the parasite is attributable to IFN-3, production. The induction of this novel NK population may provide an approach for controlling opportunistic infections in immunocompromised hosts.
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Summary CD8 + T lymphocytes have been reported to play a major role in the protective immune response against acute infection with Toxoplasma gondii. In order to further assess the role of CD8 + cells in resistance against this protozoan we examined the ability of B2m-deficient mice, which fail to express MHC class I molecules and peripheral CD8 + lymphocytes, to survive tachyzoite challenge following vaccination with an attenuated parasite mutant. Surprisingly, vaccination of B2m-deficient mice induced strong resistance to lethal challenge, with >50% surviving beyond 3 months. Vaccinated ~2m-deficient mice, but not control heterozygotes, showed a five-to sixfold expansion in spleen cell number and "~40% of the splenocytes were found to express the NK markers NKI.1 and asialo GMI. Spleen cells from the vaccinated/~2m-deficient animals failed to kill either infected host cells or the NK target YAC-1. However, high levels of IFN-3~ were secreted when the cells were cultured in vitro with soluble T. gondii lysate, and this response was abolished by NKI.1 § but not CD4 + and CD8 § lymphocyte depletion, implicating the NKI.1 + population as the major source of IFN-% More importantly, vaccine-induced immunity in fl2m-deficient mice was completely abrogated by in vivo administration of antibody to NKI.1, asialo GM1, or IFN-% Together, the data suggest that in class I-deficient mice vaccinated against T. gondii, the absence of CD8 + effector cells is compensated for by the emergence of a population of NKI.1 + and asialo GM1 + cells which lack cytolytic activity, and that the protective action of these cells against the parasite is attributable to IFN-3, production. The induction of this novel NK population may provide an approach for controlling opportunistic infections in immunocompromised hosts.
I nfection with the intracellular protozoan Toxoplasma gondii
is characterized by an acute proliferative stage, during which infective tachyzoites invade and replicate within a wide variety of host cells, and a chronic slow growing phase consisting of parasite encystment within tissues of the brain and muscle. Although infection is usually innocuous, in immunocompromised hosts encysted parasites can reactivate, leading to uncontrolled tachyzoite proliferation, tissue damage, and encephalitis, which in some cases leads to host death (1) .
Control of both acute and chronic infection is largely dependent upon the cytokine IFN-% Thus, neutralization of endogenous IFN-3' by in vivo administration ofmAb renders mice susceptible to primary infection with the normally avirulent T. gondii strain ME49 (2) and ablates protective immunity induced by vaccination with the attenuated mutant ts-4 (3). Prevention of toxoplasma encephalitis is also dependent upon the activity of IFN-% since treatment of chronically infected mice with anti-IFN-3~ mAb leads to reactivation of acute infection (4, 5) , and administration of recombinant IFN-7 reduces both tachyzoite numbers and inflammation in these animals (6) .
While both CD4 + and CD8 + T lymphocytes from immune mice secrete large amounts of IFN-7 in vitro in response to tachyzoites (7), CD8 + cells are likely to be the major source oft cell-derived IFN-y in vivo. Thus, immune CD8 + cells transfer resistance to naive recipients more efficiently than CD4 + cells (8) , and this effect is abrogated by simultaneous treatment with anti-IFN-3r mAb (9) . Similarly, vaccine-induced immunity is abrogated by CD8 + cell depletion, and while CD4 + depletion during vaccination results in failure to generate protection, it has no effect on resistance to challenge infection once immunity is established (3) . On the basis of this evidence, it has been argued that CD8 + cells are the major effectors of the IFN-3~-dependent protective response and that their generation is dependent upon CD4 + helper function (7, 8) .
In order to further define the role of CD8 + T lymphocytes in immunity to Toxoplasma, we examined the response of MHC class I-deficient mice following vaccination with the attenuated T. gondii mutant ts-4. These animals were constructed by targeted disruption of the gene encoding the 82 microglobulin (/$zm) subunit of the class I molecule (10), As a result, the peripheral CD8 + compartment fails to develop (11) and the mice fail to display normal resistance to infection with Trypanosoma cruzi (12) , Mycobacterium tuberculosis (13) and certain viruses (14) . As described below, ~2m-deficient mice unexpectedly were found to develop high levels of protective immunity to T. gondii following vaccination. This resistance was associated with a massive parasite-induced expansion of a splenocyte population expressing NKI.1 and asialo GMt (ASGMt), 1 phenotypic markers characteristic of NK cells. The latter population, while producing IFN-~/in response to parasite Ag, was unable to mediate lysis of either T. gondii-infected host cells or conventional NK targets, and thus appears to be functionally unique. The appearance of these cells in CD8 + deficient animals suggests that they could be induced as alternative effectors of parasite immunity in immunodeficient hosts.
Materials and Methods
Mice and Parasites. Chimeric mice homozygous (-/-) for the disrupted/~2m gene were derived from (129 x B6)F2 founder stock as described (10) . Animals used in this study were from the fifth backcross generation. Control animals heterozygous for the inactive ~zm gene (+/-) were obtained by crossing -/-mice with C57B1/6 animals purchased from The Jackson Laboratory (Bar Harbor, ME). Animals were bred and maintained under specific pathogen-free conditions. The KH and ts-4 strains of T. gondii were maintained by weekly passage in vitro on human fibroblasts at 37~ and 34~ respectively.
T. gondii Ag Preparation. Soluble T. gondii Ag was prepared as described in detail elsewhere (15) . Briefly, RH tacbyzoites harvested from the peritoneal cavity of Swiss-Webster mice were sonicated in the presence of protease inhibitors, centrifuged at 10,000g, dialyzed into PBS, filtered through a 0.2-#m membrane (Costar Corp., Cambridge, MA), and stored in aliquots at -80~ until use.
Antibodies. (17) . Biotinylated mAb 30Fl1.1 (anti-CD45) and 145-2Cll were purchased from PharMingen. Anti-ASGM1 mAb (18) was kindly provided by Dr. T. Higgins (University of Pennsylvania) and biotin labeled as described (19) . The antibodies were used at dilutions predetermined to give optimal staining by flow cytometric analysis. For in vivo cell depletions mAb XMG1.2 (anti-IFN-3,), PK136, GK1.5 (anti-CD4), and GLl13 (anti-/3-galactosidase), rabbit antiserum specific for ASGM1 (Wako Chemicals, Richmond, VA), 1 Abbreviation used in this paper: ASGM1, asialo GMI. and normal rabbit serum were used. The Ab were partially purified by precipitation from ascites fluid with 40% ammonium sulfate, and sterilized by filtration through a 0.2-pm membrane (Costar Corp.) prior to use. In vitro depletions employed hybridoma culture supernatants ofmAb RL172.4 (anti-CD4), 3-155 (anti-CD8), and SW3A4 (anti-NKl.1).
Vaccination and Challenge. Mice were vaccinated by biweekly intraperitoneal injections of 2 x 104, 2 x 105, and 2 x 105 ts-4 tachyzoites, then challenged 2 wk later by subcutaneous injection of 2000 virulent RH strain tachyzoites.
In Vivo Cell Depletion. To assess the role of NK cells and IFN-y in resistance, some groups of mice were depleted of NKI.1 + cells or IFN-3, by twice weekly injections of 2 mg of mAb PK136 (16) or XMG 1.2 i.p. beginning 3 d prior to challenge. Control mAb (GLl13) was administered under similar conditions. ASGM/~ cells were depleted by twice weekly injection of 50 ~1 i.p. of rabbit antiserum specific for ASGM1. Similarly prepared normal rabbit serum was administered to mice under identical conditions. Efficacy of cell depletions, determined by flow cytometric analysis, was 90-95%.
In Vitro Cell Depletion. Splenocytes were depleted of specific cell populations using mAb and rabbit serum as a source of complement (Accurate Chemical and Scientific Corp., Westbury, NY). Cells (1.5 x 10 s) were incubated in 2.5 ml mAb-containing culture supematant (45 min, 0~ washed, incubated (45 min, 37~ in 5 ml of a 1:10 dilution of rabbit serum as a source of complement (Accurate Chemical and Scientific Corp.), washed, and the Ab + complement treatment was repeated. Specificity of depletions was confirmed by flow cytometry.
Flow Cytometric Analysis. Spleen cells were first treated with
ammonium chloride/potasium bicarbonate lysis buffer (B and B Research Laboratories, Inc., Fiskeville, ILl) to remove red cells. Samples containing 106 cells were incubated with Ab (diluted in 50 #1 HBSS supplemented with 1% FCS and 0.1% sodium azide) for 30 min at 0~ and then washed. Staining was performed in the presence of saturating levels of unlabeled Fc receptor specific antibody (2.4G2) to block nonspecific Fc receptor binding. In the case of biotin-labeled mAb, after Ab staining cells were washed and incubated (30 min, 0~ in avidin conjugated to PE (PharMingen; 50 #1 of a dilution predetermined to be optimal). Cells were washed and analyzed on an EPICS 753 flow cytometer (Coulter Corporation, Hialeah, FL) for 1-and 2-color analyses (10,000 cells per sample). Dead cells were excluded by propidium iodide gating.
Measurement of In Vitro IFN-7
Response. Splenocytes and splenocyte subpopulations from ts-4 vaccinated mice (5 x 106/well or 3 x 10S/weU, as indicated) were cultured for 72 h in the presence of soluble T. gondii Ag (50-100/~g/ml) and IFN-3~ was measured in a two-site capture ELISA using immobilized mAb HB170 (anti-IFN-3r), rabbit polyclonal anti-mouse IFN-% and peroxidaseconjugated donkey anti-rabbit Ig (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).
Cytolytic Assays. Splenocytes from nonvaccinated, ts-4 vaccinated, and poly I:C injected mice were tested for the ability to kill the NK sensitive target YAC-1 in a SlCr release assay. To induce NK cell activity, 50 #g poly I:C (Sigma Chemical Co., St. Louis, MO) was administered intraperitoneally to nonvacdnated mice 24 h before assay. S1Cr-labeled YAC-1 targets (104/weU) were incubated with splenocytes, and chromium released into the supernatant was measured after 5 h using a supernatant harvesting press (Skatron, Lier, Norway).
Lytic activity of splenocytes for T. gondii-infected target bone marrow macrophages was measured in a 5~Cr release assay as previously described (20) . Briefly, target macrophages were cultured 
Results

fl2m-deficient Mice Develop High Levels of Resistance to T. gondii challenge. Both nondeficient +/-and deficient -/-
mice (heterozygous and homozygous, respectively, for the defective/32m gene) succumbed within 14 d when inoculated with the virulent T. gondii strain RH without prior vaccination (Fig. 1) . As previously shown for other mouse strains (3, 8, 21) , +/-animals when vaccinated with tachyzoites of the temperature-sensitive mutant ts-4 showed complete resistance to challenge with RH ( Fig. 1 A) . Unexpectedly,/32m-deficient -/-mice also displayed a high degree of resistance following T. gondii vaccination, with 55 % of the animals surviving for at least 60 d after challenge (Fig.  1 B) . Resistance in both mouse strains was dependent upon IFN-% since treatment of mice with antibody to this cytokine completely abrogated immunity (Fig. 1, A and B) . Administration of a rat IgG mAb of irrelevant specificity (/3-galactosidase) had no effect on the ability of either stain to resist challenge infection (data not shown).
Vaccination of j82m-def~ient Mice Induces Ex~nsion of NKl.1 + Cells. In order to investigate the mechanism by which B2m-deficient mice resist RH challenge, we examined the splenocyte populations from vaccinated and nonvaccinated animals. A dramatic fve-to six-fold increase in spleen cell number was observed in ts-4 immunized -/-animals. In contrast, no significant increase in splenocytes was seen in vaccinated +/-or nonvaccinated -/-mice. As expected, flow cytometric analysis revealed only low levels of class I (H-2K b) and CD8 expression in spleen cells from -/-animals ( Table 1 ). In addition, no CD8 + lymphocytes were detected in the peritoneum (data not shown), a site where these cells have recently been detected in fl2m-negative mice injected with tumor cells (22) . Instead, we found a striking increase (from 5 to 39%; Table 1 and Fig. 2 ) in the percent of splenocytes expressing the NK marker NKI.1 in vaccinated -/-animals. In contrast, only a minor increase in NKI.1 + cells (3-7%) was induced by vaccination of +/-animals. The level of CD4 § lymphocytes was 10-15% lower in vaccinated fl2m-deficient than in nonvaccinated -/-and vaccinated +/-mice, this decrease most probably reflecting the increased percent of NKI.1 § cells. to ensure exclusion of NKI.1 -cells. In this cell staining experiment, as in the others shown, saturating levels of unlabeled mAb 2.4G2 were included to block nonspecific Fc receptor binding. Cells stained with FITC-labeled NKI.1 + alone showed no PE fluorescence (Fig. 3 A) but virtually all of the NKI.1 + cells expressed ASGM1 (Fig. 3 B) . In contrast, minimal staining was detected with mAb specific for Thyl.2 (5%; Fig. 3 C) , CD4 (2%; Fig. 3 D) , and o~B TCR (3%; Fig. 3 F) . However, a small amount of staining (12%; Fig. 3 H) was detected using 5E6, a mAb detecting a marker associated with a subpopulation of NK cells (17) . In addition, a minor population of NKI.1 + cells was found to express CD3 (14%; Fig. 3 E) and 'y6 TCR (14%; Fig. 3 G) . The similar proportion of NKI.1 + cells expressing the latter markers suggested they were produced by the same subpopulation of cells, and indeed 3-color cytometric analysis using mAb to NKI.1, CD3, and "y8 TCR confirmed this to be the case (data not shown).
Cytotoxic Activity ofT. gondii-induced NKI.I + Cells.
The large increase in NKI.1 + cells was unexpected because it has recently been shown that ~zm-deficient mice are defective in NK cell lytic activity (23, 24) . We similarly found that poly I:C treatment of nonvaccinated -/-mice resulted in Effector: Target a much smaller enhancement of cytolytic function relative to that stimulated in +/-mice (Fig. 4) . Moreover, splenocytes from T. gondii vaccinated class I-deficient mice, although composed of up to 40% NKI.1 § cells, were unable to lyse YAC-1 targets (Fig. 4 B) . The ability of splenocytes from vaccinated mice to kill tachyzoite-infected host cells was also assessed. As shown previously (20, 25) , vaccination of normal (+/-) animals generated splenic effector cells capable of lysing parasite-infected bone marrow macrophages (Fig. 5 A) . A low but significant level of killing (10% specific StCr-release; p <0.05) was detected using restimulated +/-effectors and infected -/-targets (Fig. 5 A) . The latter could possibly be mediated by a low level of functionally conformed cell surface class I heavy (Table 2) . Similarly, after in vivo NK cell depletion, splenocytes synthesized only low levels of IFN-'y (7 ng/ml) foUowing in vitro stimulation with parasite extract, and this response was abolished by lysis of T cells prior to culture (Table 2 ). In addition, removal of CD3 + 7/~TCR + cells in the NKI.1 + population by cell sorting did not alter the ability of the remaining ceUs to secrete IFN-3' in response to parasite Ag (data not shown).
Vaccine-induced Protection in ~2m-deficient Mice is Dependent Upon NKI.1 + and ASGMf" Cells. Since the vaccineinduced NKI.1 + cells produce IFN-qr in vitro in response to T. gondii triggering (Table 2) , and the protective response in class I-deficient animals is dependent upon this cytokine (Fig. 1 B) , we assessed the effects of in vivo depletion of NK cells on the resistance of these mice to challenge infection. While administration of anti-NKl.1 mAb or rabbit anti- ASGM1 antibodies failed to alter the ability of vaccinated +/-mice to resist challenge infection (Fig. 6 A) , the same antibody treatments were found to completely abrogate vaccine-induced immunity in 32m-deficient animals (Fig. 6  B) . As expected, CD8 § depletion did not alter the ability of the class I-deficient mice to resist challenge (data not shown). T. gondii challenge contrasts with previously reported experiments demonstrating an inability of these animals to survive infection with Trypanosoma cruzi (12) , Mycobacterium tuberculosis (13) , and a virulent influenza strain (14) . However, ~2m-negative mice are able to dear infections with other influenza strains (14, 29) as well as vaccinia and Sendai virus (30, 31) .
Indeed, while not as striking as the response to T. gondii, vaccinia-infected 32m-negative mice have greater numbers of spleen cells than do normal heterozygotes, and part of this increase is due to non-B, non-T cells (30) . Therefore, it is possible that control of these infections is attributable to the induction of a protective NKI.1 + cell population similar to that described here. Recent reports have suggested that class I molecules play a role in driving differentiation of NK cells, as evidenced by decreased cytolytic activity of poly I:C induced NK cells from B2m-deficient mice (23, 24) . We also found that poly I:C treatment of nonvaccinated -/-mice resulted in a much smaller enhancement of cytolytic function relative to that stimulated in +/-mice. Furthermore, NKI.1 + cells from vaccinated mice fail to exhibit cytolytic activity, although they secrete IFN-3, in response to parasite Ag. These observations demonstrate that target cell killing and cytokine (IFN-30 production are independent and dissociable activities of NKI.1 + and ASGMI+ cells, and that intact class I dimers per se, while important for generation of cytolytic NK activity (32), do not appear to be required for differentiation of cytokine-secreting cells of this phenotype. We do not know at present if the parasite-induced NKI.1 + cells are derived from an independent lineage relative to cytolytic NK cells, or whether the cytolytic mechanism of these cells is inoperational by virtue of the fact that they are generated in the absence of class I molecules.
The results presented here suggest that in the immune system of class I-deficient animals loss of IFN-'r-producing CD8 + lymphocytes is compensated for by production of an unconventional effector cell population capable of producing the same cytokine. The production of novel effector cells in response to immunodeficiency has also been observed in B2m-negative mice infected with Sendai virus (31) . Such mice clear the virus, albeit with delayed kinetics relative to normal mice, and although CD8 + CTL activity is responsible for virus elimination in class I-expressing animals, in the immunodeficient mice clearance is attributable to the appearance of CD4 + CTL. Similarly, infection of ~2m-negative animals with murine lymphocytic choriomeningitis virus induces splenic CD4 + CTL activity (33) . However, it is unlikely that CD4 + cytolysis plays a major role in the protective response of class I-deficient mice infected with T. gondii because virtually no CD4 + cells were detected in the protective NKI.1 + population, and no cytolytic activity was detected against parasite-infected cells using splenocyte effectors from vaccinated B2m-negative mice. In addition, immunity was completely eliminated by IFN-qr depletion, implicating this cytokine as the major mediator of immunity rather than cell-mediated cytolytic activity. Nevertheless, since IL-2 induces NK cell proliferation (34) , conventional CD4 + lymphocytes could play a helper role in the induction and activity of these cells; this possibility is currently being examined.
Depletion of NKI.1 + cells in ts-4 vaccinated +/-mice had no effect on resistance to T. gondii, indicating that such cells probably do not play a major role during the effector phase of immunity in these animals. However, NK cell lytic activity has been detected in other experimental models used to study T. gondii (35) (36) (37) and it is possible that in these cases, as with the class I-deficient mice, NKI.1 + cells provide a source of protective IFN-'y. In addition, parasite induction of NKI.1 + cells at initial stages of infection may result in early T cell-independent IFN-y production, which could in turn drive immunity to the predominant Thl type of CD4 + response characteristic of T. gondii infection (3).
The results of the present study provide a dramatic demonstration of in vivo induction of IFN-3' producing NKI.1 + cells in response to microbial stimulation. In addition, our findings unequivocally establish that such cells confer strong resistance to challenge with a normally lethal pathogen. Recently, we have shown in an in vitro system that spleen cells and bone marrow derived NK cells from SCID mice produce IFN-3~ when cultured with live T. gondii parasites or tachyzoite extract (28) . This response, like that induced by the intracellular bacterium Listeria monocytogenes (38, 39) , is dependent upon TNF-ot and IL-12 released by macrophages after microbial stimulation (40, 41) . Preliminary evidence indicates that the NKI.1 + cells induced in vaccinated ~zm-negative mice are triggered to produce IFN-3' by a similar accessory cell dependent pathway.
In addition to demonstrating in vivo induction of protective NKI.1 + cells in response to microbial infection, the results of this study provide a major example of redundancy and adaptability in the murine immune system. Furthermore, the ability of a defective host immune system to utilize alternate pathways to produce protective IFN-3' has important clinical implications. Thus, in the case of toxoplasmosis and other opportunistic infections, this property could potentially be exploited to induce T independent resistance in immunocompromised hosts.
